Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial

A Gentili, MF Godschalk, D Gheorghiu… - European journal of …, 1996 - Springer
A Gentili, MF Godschalk, D Gheorghiu, K Nelson, DA Julius, T Mulligan
European journal of clinical pharmacology, 1996Springer
Objective: To study the acute effect of clonidine, an α 2-adrenoceptor agonist, and
yohimbine, an α 2-adrenoceptor antagonist, on nocturnal sleep in healthy men. Setting:
McGuire Veteran Affairs Medical Center, Richmond, Virginia, USA. Subjects: Eight healthy
male volunteers. Methods: Each subject slept in the sleep laboratory for 2 consecutive nights
on three separate sessions, at 3-week intervals. On the 2nd night of each session, the
subjects received yohimbine (5.4 mg), clonidine (0.1 mg), or placebo in a double-blind …
Abstract
Objective: To study the acute effect of clonidine, an α2-adrenoceptor agonist, and yohimbine, an α2-adrenoceptor antagonist, on nocturnal sleep in healthy men.
Setting:
McGuire Veteran Affairs Medical Center, Richmond, Virginia, USA.
Subjects:
Eight healthy male volunteers.
Methods:
Each subject slept in the sleep laboratory for 2 consecutive nights on three separate sessions, at 3-week intervals. On the 2nd night of each session, the subjects received yohimbine (5.4 mg), clonidine (0.1 mg), or placebo in a double-blind, randomized, placebo-controlled, crossover design.
Results:
There were no apparent effects of yohimbine. In contrast, clonidine completely suppressed rapid eye movement (REM) sleep in one subject and reduced REM sleep in the remaining seven subjects.
Conclusion:
Our study confirms that clonidine markedly decreases REM, even at a low single dose, and supports the hypothesis of the important role of α2-receptors in controlling REM sleep.
Springer